20 Years After iPS Cell Discovery, Regenerative Medicine Enters the Age of 'Efficiency and Automation' — The Key to Making It 'Everyday' Healthcare
RX Japan will host the Regenerative Medicine EXPO Tokyo at Makuhari Messe from May 20-22, 2026. Two decades after the birth of iPS cells, the focus has shifted toward industrializing regenerative medicine through AI, robotics, and automation to overcome high costs and labor-intensive processes.
📋 Article Processing Timeline
- 📰 Published: May 18, 2026 at 20:50
- 🔍 Collected: May 18, 2026 at 12:31
- 🤖 AI Analyzed: May 18, 2026 at 13:00 (28 min after Collected)
RX Japan Ltd. (Chuo-ku, Tokyo; President: Takeshi Tanaka) will host 'Regenerative Medicine EXPO Tokyo / INTERPHEX Week Tokyo' for three days from May 20 (Wed) to 22 (Fri), 2026, at Makuhari Messe.
Nearly 20 years have passed since the birth of iPS cells. While regenerative medicine is progressing as an innovative treatment for intractable diseases, major barriers remain for its widespread social implementation:
- Extremely high treatment costs ranging from several million to tens of millions of yen.
- Cultivation and manufacturing processes dependent on highly skilled technicians.
- Production efficiency issues due to quality variations and long working hours.
Against this backdrop, the 'social implementation of regenerative medicine' through efficiency and automation of the entire manufacturing process is garnering significant attention.
■ From 'Medical Technology' to 'Industrial Process'
In recent years, DX (Digital Transformation) utilizing AI and robotics has been rapidly advancing in the pharmaceutical and bio industries. The core focus is the sophistication of the following processes:
- Growing (Cultivation): Automation of cell manufacturing and 24-hour operation.
- Evaluation (Quality Assessment): Standardization and quantification via AI.
- Protection (Sterility and Safety Management): Labor-saving in inspection and environmental management.
By optimizing these as an integrated whole, regenerative medicine is evolving from 'man-made medicine' into an 'industrially stable production industry.'
This exhibition will bring together cutting-edge solutions representing this transition, including cell culture automation, AI-based quality evaluation, and mass production technologies.
■ Exhibitors and Products (Selected Excerpts)
The venue will showcase core technologies supporting the mass production of regenerative medicine:
- Automated Cell Culture System: CellMeister
Combines core technologies such as sorting/dispensing, robot handling, cultivation, and clean technology to develop and manufacture all-in-one custom devices tailored to client protocols.
Example: Stable cell culture achieved through robot handling mimicking human techniques.
[Exhibitor: J-TEC Corporation]
- Automated Cell Counter: FACSCOPE B
Equipped with a fully automated X-Y-Z stage, autofocus, and class-leading image processing. Offers high-precision and reproducibility through multiple imaging modes.
[Exhibitor: Waken Btech Co., Ltd.]
- Automated Integrity Testing Device for RTP: ZEROC
A state-of-the-art device for fully automated integrity testing of alpha and beta ports in RTP (Rapid Transfer Systems) installed in isolators. Being 'fully self-contained' without the need for external electricity or pneumatic connections, it drastically enhances the safety of sterile processes.
[Exhibitor: Japan Machinery Co., Ltd.]
- Automated Detection System (Mycoplasma/Fungi/Bacteria, Sterility Testing)
A compact lab system for Rapid Microbiology Methods (RMM). Integrates everything from nucleic acid extraction to real-time PCR into a single workflow, completing the process from sample to result in just 3.5 hours.
[Exhibitor: SHENTEK]
- Tailor-made AI by Engineers Expert in Cell Biology and Chemistry
A University of Tokyo-born startup with the mission 'AI for Science, Science for AI.' They provide bespoke AI solutions specifically for R&D and manufacturing sites in medicine, cosmetics, and regenerative medicine.
[Exhibitor: IDATENase]
■ Event Overview
Regenerative Medicine EXPO Tokyo / INTERPHEX Week Tokyo
- Dates: May 20 (Wed) – 22 (Fri), 2026, 10:00 - 17:00
- Venue: Makuhari Messe, Halls 1–8
- Organizer: RX Japan Ltd.
- Co-located Shows: INTERPHEX JAPAN, in-PHARMA JAPAN, BioPharma Expo, PharmaLab EXPO, Pharma DX EXPO, CMO/CDMO EXPO
- Web: https://www.interphex.jp/tokyo/ja-jp.html
Nearly 20 years have passed since the birth of iPS cells. While regenerative medicine is progressing as an innovative treatment for intractable diseases, major barriers remain for its widespread social implementation:
- Extremely high treatment costs ranging from several million to tens of millions of yen.
- Cultivation and manufacturing processes dependent on highly skilled technicians.
- Production efficiency issues due to quality variations and long working hours.
Against this backdrop, the 'social implementation of regenerative medicine' through efficiency and automation of the entire manufacturing process is garnering significant attention.
■ From 'Medical Technology' to 'Industrial Process'
In recent years, DX (Digital Transformation) utilizing AI and robotics has been rapidly advancing in the pharmaceutical and bio industries. The core focus is the sophistication of the following processes:
- Growing (Cultivation): Automation of cell manufacturing and 24-hour operation.
- Evaluation (Quality Assessment): Standardization and quantification via AI.
- Protection (Sterility and Safety Management): Labor-saving in inspection and environmental management.
By optimizing these as an integrated whole, regenerative medicine is evolving from 'man-made medicine' into an 'industrially stable production industry.'
This exhibition will bring together cutting-edge solutions representing this transition, including cell culture automation, AI-based quality evaluation, and mass production technologies.
■ Exhibitors and Products (Selected Excerpts)
The venue will showcase core technologies supporting the mass production of regenerative medicine:
- Automated Cell Culture System: CellMeister
Combines core technologies such as sorting/dispensing, robot handling, cultivation, and clean technology to develop and manufacture all-in-one custom devices tailored to client protocols.
Example: Stable cell culture achieved through robot handling mimicking human techniques.
[Exhibitor: J-TEC Corporation]
- Automated Cell Counter: FACSCOPE B
Equipped with a fully automated X-Y-Z stage, autofocus, and class-leading image processing. Offers high-precision and reproducibility through multiple imaging modes.
[Exhibitor: Waken Btech Co., Ltd.]
- Automated Integrity Testing Device for RTP: ZEROC
A state-of-the-art device for fully automated integrity testing of alpha and beta ports in RTP (Rapid Transfer Systems) installed in isolators. Being 'fully self-contained' without the need for external electricity or pneumatic connections, it drastically enhances the safety of sterile processes.
[Exhibitor: Japan Machinery Co., Ltd.]
- Automated Detection System (Mycoplasma/Fungi/Bacteria, Sterility Testing)
A compact lab system for Rapid Microbiology Methods (RMM). Integrates everything from nucleic acid extraction to real-time PCR into a single workflow, completing the process from sample to result in just 3.5 hours.
[Exhibitor: SHENTEK]
- Tailor-made AI by Engineers Expert in Cell Biology and Chemistry
A University of Tokyo-born startup with the mission 'AI for Science, Science for AI.' They provide bespoke AI solutions specifically for R&D and manufacturing sites in medicine, cosmetics, and regenerative medicine.
[Exhibitor: IDATENase]
■ Event Overview
Regenerative Medicine EXPO Tokyo / INTERPHEX Week Tokyo
- Dates: May 20 (Wed) – 22 (Fri), 2026, 10:00 - 17:00
- Venue: Makuhari Messe, Halls 1–8
- Organizer: RX Japan Ltd.
- Co-located Shows: INTERPHEX JAPAN, in-PHARMA JAPAN, BioPharma Expo, PharmaLab EXPO, Pharma DX EXPO, CMO/CDMO EXPO
- Web: https://www.interphex.jp/tokyo/ja-jp.html
FAQ
When will the Regenerative Medicine EXPO be held?
It will be held from May 20 to 22, 2026, at Makuhari Messe.
What is the main objective of this exhibition?
To solve challenges like high costs and dependency on skilled labor through automation, facilitating the widespread use of regenerative medicine.
Who should attend this event?
Professionals from the pharmaceutical and bio industries, medical device engineers, and researchers interested in AI and robotics.